Literature DB >> 28232933

Assessment and Management of Volume Overload and Congestion in Chronic Heart Failure: Can Measuring Blood Volume Provide New Insights?

Wayne L Miller1.   

Abstract

BACKGROUND: Volume overload and fluid congestion remain primary clinical challenges in the assessment and management of patients with chronic heart failure (HF).
SUMMARY: The pathophysiology of volume regulation is complex, and the simple concept of passive intravascular fluid accumulation is not adequate. The dynamics of interstitial and intravascular fluid compartment interactions and fluid redistribution from venous splanchnic beds to the central pulmonary circulation need to be taken into account in strategies of volume management. Clinical bedside evaluations and right heart hemodynamic assessments can alert of changes in volume status, but only the quantitative measurement of total blood volume can help identify the heterogeneity in plasma volume and red blood cell mass that are features of volume overload in chronic HF. The quantitative assessment of intravascular volume is an effective tool to help guide individualized, appropriate therapy. KEY MESSAGE: Not all volume overload is the same, and the measurement of intravascular volume identifies heterogeneity to guide tailored therapy.

Entities:  

Keywords:  Blood volume quantitation; Chronic heart failure; Hemodynamic congestion; Symptomatic clinical congestion; Volume overload congestion

Year:  2016        PMID: 28232933      PMCID: PMC5260569          DOI: 10.1159/000450526

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  29 in total

1.  TRAUMATIC SHOCK: IV. A STUDY OF THE PROBLEM OF THE "LOST PLASMA" IN HEMORRHAGIC SHOCK BY THE USE OF RADIOACTIVE PLASMA PROTEIN.

Authors:  J Fine; A M Seligman
Journal:  J Clin Invest       Date:  1943-03       Impact factor: 14.808

2.  THE CHANGES IN THE DISTRIBUTION OF BODY WATER ACCOMPANYING INCREASE AND DECREASE IN EXTRACELLULAR ELECTROLYTE.

Authors:  D C Darrow; H Yannet
Journal:  J Clin Invest       Date:  1935-03       Impact factor: 14.808

3.  Comparison of estimates of right atrial pressure by physical examination and echocardiography in patients with congestive heart failure and reasons for discrepancies.

Authors:  J H Stein; A Neumann; R H Marcus
Journal:  Am J Cardiol       Date:  1997-12-15       Impact factor: 2.778

4.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure.

Authors:  L W Stevenson; J K Perloff
Journal:  JAMA       Date:  1989-02-10       Impact factor: 56.272

5.  Blood volume analysis can distinguish true anemia from hemodilution in critically ill patients.

Authors:  Philbert Y Van; Gordon M Riha; S David Cho; Samantha J Underwood; Gregory J Hamilton; Ross Anderson; L Bruce Ham; Martin A Schreiber
Journal:  J Trauma       Date:  2011-03

6.  Reliability of clinical monitoring to assess blood volume in critically ill patients.

Authors:  C R Shippy; P L Appel; W C Shoemaker
Journal:  Crit Care Med       Date:  1984-02       Impact factor: 7.598

7.  Hemodilution is common in patients with advanced heart failure.

Authors:  Ana-Silvia Androne; Stuart D Katz; Lars Lund; John LaManca; Alhakam Hudaihed; Katarzyna Hryniewicz; Donna M Mancini
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 8.  Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares.

Authors:  Paul E Marik; Michael Baram; Bobbak Vahid
Journal:  Chest       Date:  2008-07       Impact factor: 9.410

9.  Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care.

Authors:  S Chakko; D Woska; H Martinez; E de Marchena; L Futterman; K M Kessler; R J Myerberg
Journal:  Am J Med       Date:  1991-03       Impact factor: 4.965

Review 10.  Cardiorenal syndrome.

Authors:  Claudio Ronco; Mikko Haapio; Andrew A House; Nagesh Anavekar; Rinaldo Bellomo
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  2 in total

1.  Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes.

Authors:  Claire C J Dekkers; C David Sjöström; Peter J Greasley; Valerie Cain; David W Boulton; Hiddo J L Heerspink
Journal:  Diabetes Obes Metab       Date:  2019-09-17       Impact factor: 6.577

2.  Deviations From the Ideal Plasma Volume and Isolated Tricuspid Valve Surgery-Paving the Way for New Risk Stratification Parameters.

Authors:  Ena Hasimbegovic; Marco Russo; Martin Andreas; Paul Werner; Iuliana Coti; Dominik Wiedemann; Alfred Kocher; Günther Laufer; Benedikt S Hofer; Markus Mach
Journal:  Front Cardiovasc Med       Date:  2022-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.